Hawkins Puts Options Shift and Insider Buying to the Test

HWKN heads into its October 28 earnings report with options positioning at its most defensive in months, even as short sellers quietly trim their bets.

The clearest signal into the print is in options. The put/call ratio has jumped to 0.67, more than two standard deviations above its 20-day average of 0.44. That is the most hedged the options market has been on Hawkins in recent months, suggesting traders are buying downside protection ahead of the release. The shift is striking because it arrived just as the stock gained momentum: HWKN is up 3.1% on the week and 5% over the past month, closing Monday at $135.44. Borrow conditions tell a quieter story. Short interest has dropped about 8% over the past week to 5.7% of the free float, roughly 1.2 million shares. Availability is ample at 444%, meaning there are more than four shares available to lend for every share already borrowed, well clear of squeeze territory. Cost to borrow has also eased, running near 0.43%, down about 10% from a week ago. Positioning looks cautious rather than crowded: the put buyers are hedging a stock that short sellers are actually retreating from.

The bull and bear debate on Hawkins centres on whether specialty chemicals margins can recover after a soft fiscal third quarter. Bulls point to a $200 price target from BWS Financial, implying roughly 48% upside from current levels, and cite the company's three-segment structure across industrial, water treatment, and food and health sciences as a buffer against single-market weakness. Forward earnings estimates have been revised sharply higher, with HWKN ranking in the 81st percentile on 12-month forward EPS growth among peers. Barclays offers the counterpoint: the firm has cut its target twice since initiating coverage in June, most recently trimming from $142 to $141 on October 13 while keeping an Equal-Weight rating. At a trailing PE near 29.6x and EV/EBITDA of 15x, valuation is not cheap for a commodity chemicals name navigating uncertain supply chains. The mean analyst target of $174 sits 28% above the current price, but with only a handful of analysts covering the stock, that gap reflects a wide dispersion of views rather than consensus conviction.

One data point worth watching is insider behaviour. The CFO, Jeffrey Oldenkamp, made a discretionary open-market purchase of 1,290 shares at $119 in late August, spending roughly $153,500. The VP of the Water Treatment Group added another 910 shares at roughly $119 in the same week. Neither trade was made under a 10b5-1 pre-arranged plan, giving them more signal value than routine programmatic buying. The stock has since risen about 14% from those purchase prices. On the institutional side, BlackRock holds 15.1% and has been adding modestly, while Wasatch Advisors trimmed its position by 38,690 shares in the most recent reporting period.

The print will test whether HWKN's operational momentum across its water treatment and food segments can justify the premium valuation that has re-expanded alongside October's rally, even as the options market prices in more uncertainty than the share price currently reflects.